How to orchestrate cell & gene therapy supply chains
About a year and a half ago, we were asked by a client in the US to help them implement capacity planning & detailed scheduling for manufacturing and quality operations in a CAR-T cell & gene therapy production plant.
What are the insights that we have gained since then? And what have we discovered as game-changing elements in the end-to-end supply chain orchestration? You will discover it in Geert’s presentation.
- In this new market, demand is exploding but supply chain is immature
- There’s a mind shift towards a new kind of supply chain, with a lot of moving parts
- Need to be extremely agile and be able to react in real-time to volatilities in the supply chain